| ■ 영문 제목 : Global Somatostatin Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02188 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 118 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦5,124,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,686,000 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦10,248,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 소마토스타틴의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (0.25mg/pcs, 0.75mg/pcs, 3mg/pcs)와 용도별 시장규모 (호르몬 장애, 종양, 대사 장애, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 소마토스타틴 시장 점유율 - 지역별 소마토스타틴 시장규모 - 주요지역의 종류별 시장규모 (0.25mg/pcs, 0.75mg/pcs, 3mg/pcs) - 주요지역의 용도별 시장규모 (호르몬 장애, 종양, 대사 장애, 기타) - 미주의 소마토스타틴 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 소마토스타틴 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 소마토스타틴 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 소마토스타틴 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 소마토스타틴 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A., Polypeptide Laboratories, Inc, SAMARTH, UBPL, HYBIO, TianTaiShan, Yangtze River, Siyao, Shuangcheng, Hainan Zhonghe, SL PHARM, Wuhan Hualong, Qingdao Guoda, Chengdu Shengnuo, Longjin - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Somatostatin will have significant change from previous year. By the most conservative estimates of global Somatostatin market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 295.5 million in 2020. Over the next five years the Somatostatin market will register a 11.8% CAGR in terms of revenue, the global market size will reach US$ 462.1 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Somatostatin market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
0.25mg/pcs
0.75mg/pcs
3mg/pcs
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hormonal Disorder
Oncology
Metabolic Disorder
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Merck (Schweiz) AG
SANOFI-AVENTIS FRANCE
Lyomark Pharma GmbH
ALFA WASSERMANN S.p.A.
Polypeptide Laboratories, Inc
SAMARTH
UBPL
HYBIO
TianTaiShan
Yangtze River
Siyao
Shuangcheng
Hainan Zhonghe
SL PHARM
Wuhan Hualong
Qingdao Guoda
Chengdu Shengnuo
Longjin
1 Scope of the Report 2 Executive Summary 3 Global Somatostatin by Company 4 Somatostatin by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global Somatostatin Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. Somatostatin Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of 0.25mg/pcs Table 3. Major Players of 0.75mg/pcs Table 4. Major Players of 3mg/pcs Table 5. Global Somatostatin Sales by Type (2016-2021) & (K Pcs) Table 6. Global Somatostatin Sales Market Share by Type (2016-2021) Table 7. Global Somatostatin Revenue by Type (2016-2021) & ($ million) Table 8. Global Somatostatin Revenue Market Share by Type (2016-2021) Table 9. Global Somatostatin Sale Price by Type (2016-2021) Table 10. Global Somatostatin Sales by Application (2016-2021) & (K Pcs) Table 11. Global Somatostatin Sales Market Share by Application (2016-2021) Table 12. Global Somatostatin Value by Application (2016-2021) Table 13. Global Somatostatin Revenue Market Share by Application (2016-2021) Table 14. Global Somatostatin Sale Price by Application (2016-2021) Table 15. Global Somatostatin Sales by Company (2019-2021) & (K Pcs) Table 16. Global Somatostatin Sales Market Share by Company (2019-2021) Table 17. Global Somatostatin Revenue by Company (2019-2021) ($ Millions) Table 18. Global Somatostatin Revenue Market Share by Company (2019-2021) Table 19. Global Somatostatin Sale Price by Company (2019-2021) Table 20. Key Manufacturers Somatostatin Producing Area Distribution and Sales Area Table 21. Players Somatostatin Products Offered Table 22. Somatostatin Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global Somatostatin Sales by Region (2016-2021) (K Pcs) Table 26. Global Somatostatin Sales Market Share by Region (2016-2021) Table 27. Global Somatostatin Revenue by Region (2016-2021) & ($ Millions) Table 28. Global Somatostatin Revenue Market Share by Region (2016-2021) Table 29. Americas Somatostatin Sales by Country (2016-2021) & (K Pcs) Table 30. Americas Somatostatin Sales Market Share by Country (2016-2021) Table 31. Americas Somatostatin Revenue by Country (2016-2021) & ($ Millions) Table 32. Americas Somatostatin Revenue Market Share by Country (2016-2021) Table 33. Americas Somatostatin Sales by Type (2016-2021) & (K Pcs) Table 34. Americas Somatostatin Sales Market Share by Type (2016-2021) Table 35. Americas Somatostatin Sales by Application (2016-2021) & (K Pcs) Table 36. Americas Somatostatin Sales Market Share by Application (2016-2021) Table 37. APAC Somatostatin Sales by Region (2016-2021) & (K Pcs) Table 38. APAC Somatostatin Sales Market Share by Region (2016-2021) Table 39. APAC Somatostatin Revenue by Region (2016-2021) & ($ Millions) Table 40. APAC Somatostatin Revenue Market Share by Region (2016-2021) Table 41. APAC Somatostatin Sales by Type (2016-2021) & (K Pcs) Table 42. APAC Somatostatin Sales Market Share by Type (2016-2021) Table 43. APAC Somatostatin Sales by Application (2016-2021) & (K Pcs) Table 44. APAC Somatostatin Sales Market Share by Application (2016-2021) Table 45. Europe Somatostatin Sales by Country (2016-2021) & (K Pcs) Table 46. Europe Somatostatin Sales Market Share by Country (2016-2021) Table 47. Europe Somatostatin Revenue by Country (2016-2021) & ($ Millions) Table 48. Europe Somatostatin Revenue Market Share by Country (2016-2021) Table 49. Europe Somatostatin Sales by Type (2016-2021) & (K Pcs) Table 50. Europe Somatostatin Sales Market Share by Type (2016-2021) Table 51. Europe Somatostatin Sales by Application (2016-2021) & (K Pcs) Table 52. Europe Somatostatin Sales Market Share by Application (2016-2021) Table 53. Middle East & Africa Somatostatin Sales by Country (2016-2021) & (K Pcs) Table 54. Middle East & Africa Somatostatin Sales Market Share by Country (2016-2021) Table 55. Middle East & Africa Somatostatin Revenue by Country (2016-2021) & ($ Millions) Table 56. Middle East & Africa Somatostatin Revenue Market Share by Country (2016-2021) Table 57. Middle East & Africa Somatostatin Sales by Type (2016-2021) & (K Pcs) Table 58. Middle East & Africa Somatostatin Sales Market Share by Type (2016-2021) Table 59. Middle East & Africa Somatostatin Sales by Application (2016-2021) & (K Pcs) Table 60. Middle East & Africa Somatostatin Sales Market Share by Application (2016-2021) Table 61. Key and Potential Regions of Somatostatin Table 62. Key Application and Potential Industries of Somatostatin Table 63. Key Challenges of Somatostatin Table 64. Key Trends of Somatostatin Table 65. Somatostatin Distributors List Table 66. Somatostatin Customer List Table 67. Global Somatostatin Sales Forecast by Region (2021-2026) & (K Pcs) Table 68. Global Somatostatin Consumption Market Forecast by Region Table 69. Global Somatostatin Revenue Forecast by Region (2021-2026) & ($ millions) Table 70. Global Somatostatin Revenue Market Share Forecast by Region (2021-2026) Table 71. Americas Somatostatin Sales Forecast by Country (2021-2026) & (K Pcs) Table 72. Americas Somatostatin Revenue Forecast by Country (2021-2026) & ($ millions) Table 73. APAC Somatostatin Sales Forecast by Region (2021-2026) & (K Pcs) Table 74. APAC Somatostatin Revenue Forecast by Region (2021-2026) & ($ millions) Table 75. Europe Somatostatin Sales Forecast by Country (2021-2026) & (K Pcs) Table 76. Europe Somatostatin Revenue Forecast by Country (2021-2026) & ($ millions) Table 77. Middle East & Africa Somatostatin Sales Forecast by Country (2021-2026) & (K Pcs) Table 78. Middle East & Africa Somatostatin Revenue Forecast by Country (2021-2026) & ($ millions) Table 79. Global Somatostatin Sales Forecast by Type (2021-2026) & (K Pcs) Table 80. Global Somatostatin Sales Market Share Forecast by Type (2021-2026) Table 81. Global Somatostatin Revenue Forecast by Type (2021-2026) & ($ Millions) Table 82. Global Somatostatin Revenue Market Share Forecast by Type (2021-2026) Table 83. Global Somatostatin Sales Forecast by Application (2021-2026) & (K Pcs) Table 84. Global Somatostatin Sales Market Share Forecast by Application (2021-2026) Table 85. Global Somatostatin Revenue Forecast by Application (2021-2026) & ($ Millions) Table 86. Global Somatostatin Revenue Market Share Forecast by Application (2021-2026) Table 87. Merck (Schweiz) AG Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors Table 88. Merck (Schweiz) AG Somatostatin Product Offered Table 89. Merck (Schweiz) AG Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E) Table 90. Merck (Schweiz) AG Main Business Table 91. Merck (Schweiz) AG Latest Developments Table 92. SANOFI-AVENTIS FRANCE Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors Table 93. SANOFI-AVENTIS FRANCE Somatostatin Product Offered Table 94. SANOFI-AVENTIS FRANCE Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E) Table 95. SANOFI-AVENTIS FRANCE Main Business Table 96. SANOFI-AVENTIS FRANCE Latest Developments Table 97. Lyomark Pharma GmbH Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors Table 98. Lyomark Pharma GmbH Somatostatin Product Offered Table 99. Lyomark Pharma GmbH Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E) Table 100. Lyomark Pharma GmbH Main Business Table 101. Lyomark Pharma GmbH Latest Developments Table 102. ALFA WASSERMANN S.p.A. Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors Table 103. ALFA WASSERMANN S.p.A. Somatostatin Product Offered Table 104. ALFA WASSERMANN S.p.A. Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E) Table 105. ALFA WASSERMANN S.p.A. Main Business Table 106. ALFA WASSERMANN S.p.A. Latest Developments Table 107. Polypeptide Laboratories, Inc Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors Table 108. Polypeptide Laboratories, Inc Somatostatin Product Offered Table 109. Polypeptide Laboratories, Inc Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E) Table 110. Polypeptide Laboratories, Inc Main Business Table 111. Polypeptide Laboratories, Inc Latest Developments Table 112. SAMARTH Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors Table 113. SAMARTH Somatostatin Product Offered Table 114. SAMARTH Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E) Table 115. SAMARTH Main Business Table 116. SAMARTH Latest Developments Table 117. UBPL Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors Table 118. UBPL Somatostatin Product Offered Table 119. UBPL Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E) Table 120. UBPL Main Business Table 121. UBPL Latest Developments Table 122. HYBIO Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors Table 123. HYBIO Somatostatin Product Offered Table 124. HYBIO Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E) Table 125. HYBIO Main Business Table 126. HYBIO Latest Developments Table 127. TianTaiShan Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors Table 128. TianTaiShan Somatostatin Product Offered Table 129. TianTaiShan Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E) Table 130. TianTaiShan Main Business Table 131. TianTaiShan Latest Developments Table 132. Yangtze River Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors Table 133. Yangtze River Somatostatin Product Offered Table 134. Yangtze River Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E) Table 135. Yangtze River Main Business Table 136. Yangtze River Latest Developments Table 137. Siyao Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors Table 138. Siyao Somatostatin Product Offered Table 139. Siyao Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E) Table 140. Siyao Main Business Table 141. Siyao Latest Developments Table 142. Shuangcheng Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors Table 143. Shuangcheng Somatostatin Product Offered Table 144. Shuangcheng Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E) Table 145. Shuangcheng Main Business Table 146. Shuangcheng Latest Developments Table 147. Hainan Zhonghe Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors Table 148. Hainan Zhonghe Somatostatin Product Offered Table 149. Hainan Zhonghe Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E) Table 150. Hainan Zhonghe Main Business Table 151. Hainan Zhonghe Latest Developments Table 152. SL PHARM Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors Table 153. SL PHARM Somatostatin Product Offered Table 154. SL PHARM Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E) Table 155. SL PHARM Main Business Table 156. SL PHARM Latest Developments Table 157. Wuhan Hualong Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors Table 158. Wuhan Hualong Somatostatin Product Offered Table 159. Wuhan Hualong Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E) Table 160. Wuhan Hualong Main Business Table 161. Wuhan Hualong Latest Developments Table 162. Qingdao Guoda Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors Table 163. Qingdao Guoda Somatostatin Product Offered Table 164. Qingdao Guoda Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E) Table 165. Qingdao Guoda Main Business Table 166. Qingdao Guoda Latest Developments Table 167. Chengdu Shengnuo Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors Table 168. Chengdu Shengnuo Somatostatin Product Offered Table 169. Chengdu Shengnuo Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E) Table 170. Chengdu Shengnuo Main Business Table 171. Chengdu Shengnuo Latest Developments Table 172. Longjin Basic Information, Somatostatin Manufacturing Base, Sales Area and Its Competitors Table 173. Longjin Somatostatin Product Offered Table 174. Longjin Somatostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E) Table 175. Longjin Main Business Table 176. Longjin Latest Developments List of Figures Figure 1. Picture of Somatostatin Figure 2. Somatostatin Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Somatostatin Sales Growth Rate 2016-2026 (K Pcs) Figure 7. Global Somatostatin Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Somatostatin Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of 0.25mg/pcs Figure 10. Product Picture of 0.75mg/pcs Figure 11. Product Picture of 3mg/pcs Figure 12. Global Somatostatin Sales Market Share by Type in 2020 Figure 13. Global Somatostatin Revenue Market Share by Type (2016-2021) Figure 14. Somatostatin Consumed in Hormonal Disorder Figure 15. Global Somatostatin Market: Hormonal Disorder (2016-2021) & (K Pcs) Figure 16. Somatostatin Consumed in Oncology Figure 17. Global Somatostatin Market: Oncology (2016-2021) & (K Pcs) Figure 18. Somatostatin Consumed in Metabolic Disorder Figure 19. Global Somatostatin Market: Metabolic Disorder (2016-2021) & (K Pcs) Figure 20. Somatostatin Consumed in Others Figure 21. Global Somatostatin Market: Others (2016-2021) & (K Pcs) Figure 22. Global Somatostatin Sales Market Share by Application (2016-2021) Figure 23. Global Somatostatin Revenue Market Share by Application in 2020 Figure 24. Somatostatin Revenue Market by Company in 2020 ($ Million) Figure 25. Global Somatostatin Revenue Market Share by Company in 2020 Figure 26. Global Somatostatin Sales Market Share by Regions (2016-2021) Figure 27. Global Somatostatin Revenue Market Share by Region in 2020 Figure 28. Americas Somatostatin Sales 2016-2021 (K Pcs) Figure 29. Americas Somatostatin Revenue 2016-2021 ($ Millions) Figure 30. APAC Somatostatin Sales 2016-2021 (K Pcs) Figure 31. APAC Somatostatin Revenue 2016-2021 ($ Millions) Figure 32. Europe Somatostatin Sales 2016-2021 (K Pcs) Figure 33. Europe Somatostatin Revenue 2016-2021 ($ Millions) Figure 34. Middle East & Africa Somatostatin Sales 2016-2021 (K Pcs) Figure 35. Middle East & Africa Somatostatin Revenue 2016-2021 ($ Millions) Figure 36. Americas Somatostatin Sales Market Share by Country in 2020 Figure 37. Americas Somatostatin Revenue Market Share by Country in 2020 Figure 38. Americas Somatostatin Sales Market Share by Type in 2020 Figure 39. Americas Somatostatin Sales Market Share by Application in 2020 Figure 40. United States Somatostatin Revenue Growth 2016-2021 ($ Millions) Figure 41. Canada Somatostatin Revenue Growth 2016-2021 ($ Millions) Figure 42. Mexico Somatostatin Revenue Growth 2016-2021 ($ Millions) Figure 43. Brazil Somatostatin Revenue Growth 2016-2021 ($ Millions) Figure 44. APAC Somatostatin Sales Market Share by Region in 2020 Figure 45. APAC Somatostatin Revenue Market Share by Regions in 2020 Figure 46. APAC Somatostatin Sales Market Share by Type in 2020 Figure 47. APAC Somatostatin Sales Market Share by Application in 2020 Figure 48. China Somatostatin Revenue Growth 2016-2021 ($ Millions) Figure 49. Japan Somatostatin Revenue Growth 2016-2021 ($ Millions) Figure 50. Korea Somatostatin Revenue Growth 2016-2021 ($ Millions) Figure 51. Southeast Asia Somatostatin Revenue Growth 2016-2021 ($ Millions) Figure 52. India Somatostatin Revenue Growth 2016-2021 ($ Millions) Figure 53. Australia Somatostatin Revenue Growth 2016-2021 ($ Millions) Figure 54. Europe Somatostatin Sales Market Share by Country in 2020 Figure 55. Europe Somatostatin Revenue Market Share by Country in 2020 Figure 56. Europe Somatostatin Sales Market Share by Type in 2020 Figure 57. Europe Somatostatin Sales Market Share by Application in 2020 Figure 58. Germany Somatostatin Revenue Growth 2016-2021 ($ Millions) Figure 59. France Somatostatin Revenue Growth 2016-2021 ($ Millions) Figure 60. UK Somatostatin Revenue Growth 2016-2021 ($ Millions) Figure 61. Italy Somatostatin Revenue Growth 2016-2021 ($ Millions) Figure 62. Russia Somatostatin Revenue Growth 2016-2021 ($ Millions) Figure 63. Middle East & Africa Somatostatin Sales Market Share by Country in 2020 Figure 64. Middle East & Africa Somatostatin Revenue Market Share by Country in 2020 Figure 65. Middle East & Africa Somatostatin Sales Market Share by Type in 2020 Figure 66. Middle East & Africa Somatostatin Sales Market Share by Application in 2020 Figure 67. Egypt Somatostatin Revenue Growth 2016-2021 ($ Millions) Figure 68. South Africa Somatostatin Revenue Growth 2016-2021 ($ Millions) Figure 69. Israel Somatostatin Revenue Growth 2016-2021 ($ Millions) Figure 70. Turkey Somatostatin Revenue Growth 2016-2021 ($ Millions) Figure 71. GCC Country Somatostatin Revenue Growth 2016-2021 ($ Millions) Figure 72. Channels of Distribution Figure 73. Distributors Profiles |
| ※본 조사보고서 [세계의 소마토스타틴 시장예측 2021년-2026년] (코드 : LPI-2201K02188) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 소마토스타틴 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |